Novel therapeutic approach to bone metabolic disorders using RANKL vaccination
Juji, T.; Tanaka, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 2): 799-802
2004
ISSN/ISBN: 0047-1852 PMID: 15035230 Document Number: 570890
Document emailed within 1 workday
Related Documents
Mizoguchi, T. 2011: RANKL signaling and bone diseases. Quiescent osteoclast precursors and RANKL signaling Clinical Calcium 21(8): 1187-1192Kwan Tat, S.; Pelletier, J.-P.; Lajeunesse, D.; Fahmi, H.; Lavigne, M.; Martel-Pelletier, J. 2008: The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells Clinical and Experimental Rheumatology 26(2): 295-304
Goisis, C.; Grossi, F.; Cellani, F.; Bolis, P.F. 1982: New therapeutic approach in trichomoniasis: vaccination with Solcotrichovac Minerva Ginecologica 34(5): 369-384
Macovei, L.; Ancuţa, C.; Pomîrleanu, C.; Chirieac, R. 2012: Identification of bone mass and bone turnover in patients with rheumatoid arthritis treated with corticosteroids in order to elaborate an optimal therapeutic approach Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 116(2): 470-476
Schaison, G.; Bordigoni, P.; Leverger, G. 1989: Bone marrow transplantation for genetic and metabolic disorders Nouvelle Revue Francaise d'Hematologie 31(2): 119-123
Zhao, Y.; Cai, Y.; Wang, Y.-n. 2010: RANKL and OPG regulation on bone remodeling Shanghai Kou Qiang Yi Xue 19(4): 443-446
Udagawa, N.; Nakamura, M.; Takahashi, N. 2004: Possible role of RANKL in bone resorption Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 2): 97-101
Tsuda, E. 2002: Osteoclastogenesis inhibitory factor (OCIF)/OPG (a novel therapeutic candidate for the treatment of metabolic bone diseases) Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 3): 679-687
Kreutzkamp, B. 2006: New mechanism of action RANKL-antibodies reduce bone loss Medizinische Monatsschrift für Pharmazeuten 29(11): 425-426
Cloarec, D.; Florrié, B.; Marteau, P.; Galmiche, J.P. 1990: Digestive gas: pathophysiology and therapeutic approach in functional bowel disorders Gastroenterologie Clinique et Biologique 14(8-9): 641-650
Yoneda, T. 2011: Involvement of RANKL/RANK pathway in bone metastasis in breast cancer Clinical Calcium 21(8): 1159-1166
Tsuji, N.; Takahashi, F. 2007: Therapeutic agents for disorders of bone and calcium metabolism: ED-71 Clinical Calcium 17(1): 72-79
Yoneda, T. 2012: Treatment of bone metastasis by denosumab, the human monoclonal neutralizing antibody to RANKL Nihon Rinsho. Japanese Journal of Clinical Medicine 70(12): 2165-2171
Chmielewski, M.; Carrero, J.J.; Nordfors, L.; Lindholm, B.; Stenvinkel, P. 2008: Lipid disorders in chronic kidney disease: reverse epidemiology and therapeutic approach Journal of Nephrology 21(5): 635-644
Ciacli, C.; Puşchiţă, M. 2011: RANKL/RANK/OPG molecular complex--control factors in bone remodeling in psoriatic arthritis Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 115(2): 354-360
Pérez-Matute, P.; Pérez-Martínez, L.; Aguilera-Lizarraga, J.; Blanco, Jé.R.; Oteo, Jé.A. 2015: Maraviroc modifies gut microbiota composition in a mouse model of obesity: a plausible therapeutic option to prevent metabolic disorders in HIV-infected patients Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 28(4): 200-206
Makovetskaia, G.A.; Rusakova, N.V.; Lebedev, A.A. 1988: Clinical evaluation of a therapeutic complex incorporating linetol and ascorbic and nicotinic acids for the correction of lipid metabolic disorders in children with glomerulonephritis Pediatriia 1988(10): 109-110
Xu, S.; Ma, X-Xi.; Hu, L-Wei.; Peng, L-Ping.; Pan, F-Ming.; Xu, J-Hua. 2014: Single nucleotide polymorphism of RANKL and OPG genes may play a role in bone and joint injury in rheumatoid arthritis Clinical and Experimental Rheumatology 32(5): 697-704
Tropet, Y.; Garbuio, P.; Obert, L.; Grelet, V. 1998: Gunshot wounds of the extremities in civilian practice. Therapeutic approach in five cases with diaphyseal bone involvement Annales de Chirurgie Plastique et Esthetique 43(2): 162-168
Kajiwara, M.; Yajima, N.; Yamato, H. 2011: Morphological analysis of bone dynamics and metabolic bone disease. Bone histomorphometry for laboratory animals Clinical Calcium 21(4): 534-540